Breast
MRI is essential for correct surgical decision-making in patients with
breast cancer
In
women with suspected breast cancer the aim of diagnostic imaging is to
detect and accurately diagnose malignant tumors and to facilitate the
correct choice of therapy, be it mastectomy or breast-conserving surgery
with or without pre-operative neoadjuvant chemotherapy. Although
conventional mammography and ultrasound are primary imaging modalities
for women with breast cancer they have limited sensitivity and
specificity, and are associated with an increased likelihood of
inappropriate patient management if therapeutic decisions are made
solely on the basis of mammography and ultrasound findings. A
study by Pediconi et al. confirmed that contrast-enhanced breast MRI
is superior to conventional mammography and ultrasound not only in terms
of diagnostic performance but also in terms of patient management
decisions. In their study 164 consecutive women with 175 lesions
detected at conventional mammography/ultrasound subsequently underwent
pre-operative MultiHance-enhanced breast MRI. The MRI examination
revealed 51 additional lesions in 34/164 patients. Specifically,
multifocal and multicentric cancer was detected in 7 and 4 additional
patients, respectively, contralateral foci in 21 additional patients and
pectoral muscle infiltration in 2 additional patients. A further 4
patients suspected of having cancer based on mammography/ultrasound were
confirmed to be cancer-free on MRI. The sensitivity and accuracy for
malignant lesion detection and identification was 100% and 93.4%,
respectively, for MultiHance-enhanced breast MRI compared to 77.3% and
72.1 %, respectively for mammography/ultrasound. Based on MRI findings
patient management was altered for 32/164 (19.5%) patients; either more
extensive surgery with or without additional chemotherapy for 28
patients with unsuspected additional disease or a conservative approach
for the 4 patients without malignant lesions. The study highlights not
only the need for careful pre-operative work-up of women with suspected
breast cancer but also the limitations of conventional breast imaging
techniques.